Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP252658.RAHlgqQz1c_GMqA0qeUUvFX8qL3XoW4P3dQ_l-NaVdnAI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP252658.RAHlgqQz1c_GMqA0qeUUvFX8qL3XoW4P3dQ_l-NaVdnAI130_assertion type Assertion NP252658.RAHlgqQz1c_GMqA0qeUUvFX8qL3XoW4P3dQ_l-NaVdnAI130_head.
- NP252658.RAHlgqQz1c_GMqA0qeUUvFX8qL3XoW4P3dQ_l-NaVdnAI130_assertion description "[Monomeric CXCL12 preferentially activated CXCR4 signalling through G?i and Akt, whereas dimeric CXCL12 more effectively promoted recruitment of ?-arrestin 2 to CXCR4 and chemotaxis of CXCR4-expressing breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP252658.RAHlgqQz1c_GMqA0qeUUvFX8qL3XoW4P3dQ_l-NaVdnAI130_provenance.
- NP252658.RAHlgqQz1c_GMqA0qeUUvFX8qL3XoW4P3dQ_l-NaVdnAI130_assertion evidence source_evidence_literature NP252658.RAHlgqQz1c_GMqA0qeUUvFX8qL3XoW4P3dQ_l-NaVdnAI130_provenance.
- NP252658.RAHlgqQz1c_GMqA0qeUUvFX8qL3XoW4P3dQ_l-NaVdnAI130_assertion SIO_000772 22142194 NP252658.RAHlgqQz1c_GMqA0qeUUvFX8qL3XoW4P3dQ_l-NaVdnAI130_provenance.
- NP252658.RAHlgqQz1c_GMqA0qeUUvFX8qL3XoW4P3dQ_l-NaVdnAI130_assertion wasDerivedFrom befree-20150227 NP252658.RAHlgqQz1c_GMqA0qeUUvFX8qL3XoW4P3dQ_l-NaVdnAI130_provenance.
- NP252658.RAHlgqQz1c_GMqA0qeUUvFX8qL3XoW4P3dQ_l-NaVdnAI130_assertion wasGeneratedBy ECO_0000203 NP252658.RAHlgqQz1c_GMqA0qeUUvFX8qL3XoW4P3dQ_l-NaVdnAI130_provenance.